E-LIB Suche - Ergebnisse für: Suvannasankha, A.

1

P31 SINGLE-AGENT BELANTAMAB MAFODOTIN IN PATIENTS WITH RELA..:

Nooka, A. ; Cohen, A. ; Lee, H....
HemaSphere. 7 (2023) S2 - p. 27-28 , 2023

Link: https://doi.org/10.1097/..

2

P28 EFFICACY AND SAFETY OF CILTACABTAGENE AUTOLEUCEL (CILTA..:

van de Donk, N. ; Mateos, M.-V. ; Cohen, Y.C....
HemaSphere. 7 (2023) S2 - p. 25-26 , 2023

Link: https://doi.org/10.1097/..

3

P940: SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN ..:

Suvannasankha, A. ; Bahlis, N. ; Trudel, S....
HemaSphere. 6 (2022) - p. 830-831 , 2022

Link: https://doi.org/10.1097/..

4

Retreatment with ribavirin and interferon alpha 2b of relap..:

Munoz, S. ; Suvannasankha, A. ; DiGregorio, K....
Gastroenterology. 114 (1998) - p. A1307 , 1998

Link: https://doi.org/10.1016/..

5

1q amplification and PHF19 expressing high-risk cells are a..:

Johnson, Travis S. ; Sudha, Parvathi ; Liu, Enze...
Nature Communications. 15 (2024) 1 - p. , 2024

Link: https://doi.org/10.1038/..

6

Safety and efficacy of belantamab mafodotin with pembrolizu..:

Suvannasankha, Attaya ; Bahlis, Nizar ; Trudel, Suzanne...
Cancer. , 2024

Link: https://doi.org/10.1002/..

7

OA-27 Single cell transcriptomics reveals the impact of tum..:

Sudha, Parvathi ; Zaid, Mohammad Abu ; Johnson, Travis...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S16-S17 , 2023

Link: https://doi.org/10.1016/..

8

Nivolumab and daratumumab combination regimens for the trea..:

Abdallah, Al-Ola ; Lesokhin, Alexander ; Wrobel, Tomasz...
Frontiers in Hematology. 2 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

9

Identifying novel mechanisms of biallelic TP53 loss refines..:

Liu, Enze ; Sudha, Parvathi ; Becker, Nathan...
Blood Cancer Journal. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

10

Single‐agent belantamab mafodotin in patients with relapsed..:

Nooka, Ajay K. ; Cohen, Adam D. ; Lee, Hans C....
Cancer. 129 (2023) 23 - p. 3746-3760 , 2023

Link: https://doi.org/10.1002/..

11

P-044 Evaluation of the efficacy and safety of two differen..:

Richter, Joshua ; Bumma, Naresh ; Dhodapkar, Madhav...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S58-S59 , 2023

Link: https://doi.org/10.1016/..

12

P-247 Efficacy and safety of linvoseltamab 200 mg in patien..:

Dhodapkar, Madhav ; Bumma, Naresh ; Richter, Joshua...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S172 , 2023

Link: https://doi.org/10.1016/..

13

P-240 Efficacy and safety of ciltacabtagene autoleucel in p..:

Cohen, Adam ; Cohen, Yaël ; Suvannasankha, Attaya...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S167-S168 , 2023

Link: https://doi.org/10.1016/..

14

P-005 Association of baseline soluble BCMA with measures of..:

Boyapati, Anita ; Richter, Joshua ; Suvannasankha, Attaya...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S35 , 2023

Link: https://doi.org/10.1016/..

15

Cilta-Cel Efficacy and Safety in Patients with Progressive ..:

Suvannasankha, Attaya ; Mateos, Maria-Victoria ; Cohen, Yael C...
Transplantation and Cellular Therapy. 29 (2023) 2 - p. S395-S396 , 2023

Link: https://doi.org/10.1016/..